This story has been viewed 551 times and has No comments

Posted by: admin on: October 14, 2011

  • Facebook
  • Twitter
  • Delicious
  • Digg
  • StumbleUpon
  • Add to favorites
  • Email
  • RSS

Biomarker Bulletin  is a weekly/biweekly update of news focused on biomarkers aggregated at BiomarkerCommons.org. Biomarkers are physical, functional or biochemical indicators of normal physiological or disease processes.

The individualization of disease management — personalized medicine — is dependent on developing biomarkers that promote specific clinical domains, including early detection, risk, diagnosis, prognosis and predicted response to therapy.

  • Biomarker Combinations Successfully Discriminate Between Asthma and COPD
    Researchers in Australia have identified a panel of four biomarkers that may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease (COPD). The study, published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, found that the biomarkers may be used in different combinations to successfully identify patients with either of the airway diseases.
  • Plasma Biomarkers in Liver Cancer Refine Stratification of Patient Risk
    According to an Internal Medicine News report, data presented at the 2011 Gastrointestinal Cancers Symposium at the American Society of Clinical Oncology meeting on gastrointestinal cancers in January sponsored by the American Society of Clinical Oncology suggests that a simple blood test may improve on systems conventionally used to estimate prognosis in patients with hepatocellular carcinoma.
  • Xention to Characterize Biomarkers for AF Consortium
    Cambridge-based biopharmaceutical company Xention announced yesterday that it is a partner in the new multidisciplinary atrial fibrillation research consortium, the European Network for Translational Research in Atrial Fibrillation (EUTRAF). The consortium has been awarded a 12 million euro grant to engage in atrial fibrillation (AF) research.
  • Five Metabolite Levels May Improve Risk Prediction for Diabetes
    Researchers at Massachusetts General Hospital (MGH) recently identified five amino acids whose levels indicated increased diabetes risk in a general population. Moreover, the biomarkers could differentiate, among individuals with traditional risk factors such as obesity, those most likely to actually develop diabetes. The findings are published in the journal Nature Medicine.
  • Endothelial Microparticles (EMPs) in the Blood Useful for Identifying Early Signs of Emphysema
    According to a recent study published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, small particles in the blood released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages. The particles, called endothelial microparticles (EMPs), are shed during disease progression as pulmonary capillaries in the lungs are injured and die.

Ref:    http://www.highlighthealth.com/biomarker-bulletin/biomarker-bulletin-april-5-2011/

Share and Enjoy

Leave a Reply

Your email address will not be published. Required fields are marked *


*

CMHF Accredited by Maharashtra Medical Council

Subscribe to our Posts

Enter your email address:



  • drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
  • rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
  • nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards

Events

  • No events

Calculate Your Body Mass Index



Check your Body Mass Index »

    Orange - 45 kcal in 100g
    45kcal
    Orange - 45 kcal in 100g
    by Noni

Calendar

October 2011
M T W T F S S
« Sep   Nov »
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Sat
30°C
Sun
30°C
Mon
31°C
29°C
Scattered Clouds
Weather Report
Wind: 11mph WSW
Humidity: 96%